Concepedia

Publication | Closed Access

ClarIDHy: A global, phase III, randomized, double-blind study of ivosidenib (IVO) vs placebo in patients with advanced cholangiocarcinoma (CC) with an isocitrate dehydrogenase 1 (IDH1) mutation

DOI

88

Citations

0

References

2019

Year

Ghassan K. Abou‐Alfa, T. Macarulla Mercadé, Milind Javle, Robin Kate Kelley, Sam Joseph Lubner, Jorge Adeva, James M. Cleary, Daniel V.T. Catenacci, Mitesh J. Borad, J.A. Bridgewater,
Annals of Oncology

No additional data available for this publication yet. Check back later!